Bellion Spirits LLC was properly barred from advertising supposed DNA-related health benefits of its vodka because it failed to provide scientific support for its proposed claims, making them misleading, a federal appeals court in the District of Columbia affirmed Friday.
Bellion infuses its vodka with NTX, a proprietary blend that Bellion contends mitigates alcohol’s damage to a person’s DNA. The company sought regulatory permission to claim that “NTX helps protect DNA from alcohol-induced damage” and “NTX reduces alcohol-induced DNA damage.”
The Alcohol and Tobacco Tax and Trade Bureau found the health claims weren’t supported by credible evidence and created a ...
Learn more about Bloomberg Law or Log In to keep reading:
Learn About Bloomberg Law
AI-powered legal analytics, workflow tools and premium legal & business news.
Already a subscriber?
Log in to keep reading or access research tools.